BioGenes GmbH, founded in 1992, is a world-wide acting full-service provider for customised immunoassay and antibody development with strong commitment to quality and service. For more than 18 years BioGenes is spezialised in custom development of Host Cell Protein ELISAs including analysis as well as the production of generic HCP ELISAs.
Our scientists possess an unrivaled expertise in ELISA development, validation and production for biotech, pharma, medical device and clinical diagnostic applications. Their extensive antibody know-how allows for complex antibody development.
BioGenes is certified to meet the international requirements and regularities of quality assurance and animal welfare and maintains long-term alliances with biotech and pharmaceutical companies as well as research institutes all over the world.